Compare ATYR & DRDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATYR | DRDB |
|---|---|---|
| Founded | 2005 | 2024 |
| Country | United States | United States |
| Employees | 58 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.6M | 320.5M |
| IPO Year | N/A | N/A |
| Metric | ATYR | DRDB |
|---|---|---|
| Price | $0.92 | $10.52 |
| Analyst Decision | Hold | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $3.67 | N/A |
| AVG Volume (30 Days) | ★ 957.5K | 213.3K |
| Earning Date | 05-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $597.54 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.64 | $10.16 |
| 52 Week High | $7.29 | $10.55 |
| Indicator | ATYR | DRDB |
|---|---|---|
| Relative Strength Index (RSI) | 57.72 | 59.74 |
| Support Level | $0.68 | $10.50 |
| Resistance Level | $1.12 | $10.55 |
| Average True Range (ATR) | 0.06 | 0.01 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 57.49 | 66.67 |
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
Roman DBDR Acquisition Corp II is a blank check company.